Episode 111: BioRestorative Therapies Inc. on Stem Cell Therapies to Help Patients with Prevalent Conditions

Lance Alstodt, President, CEO, and Chairman of the Board of BioRestorative Therapies Inc. (NASDAQ: BRTX) talks about the mission of the Company in meeting the unmet needs of patients with highly prevalent conditions through stem cell therapies. BioRestorative Therapies currently has two primary platform technologies addressing chronic back pain caused by disc degeneration (BRTX-100), and metabolic disorders including obesity and diabetes (ThermoStem). In this interview, Lance talked about their impressive portfolio of patents, the actions they are taking to expand their intellectual products position, and their strong and pristine financial metrics, giving them significant capital to prosecute clinical programs.

Lance also mentioned that they have major discoveries that are yet to be announced.  Keep updated about BioRestorative Therapies Inc. products and breakthroughs by visiting their website: https://www.biorestorative.com.